The Stralem Fund – US Equity (UCITS)

An investor should consider the investment objectives, risks, charges and expenses of the Fund carefully before investing. Click below for the Prospectus, which contains this and other important information, or contact the General Distributor at +44 22 705 1178 or Please read the Prospectus carefully before investing. The Fund may not be suitable for all investors.

Swiss (French)


How to invest

Investments should be made only after a thorough reading of the current legal Prospectus and the latest Annual and Semi-Annual Reports. Prospective investors should not view the contents of the Prospectus as legal, tax or investment advice. Each investor should consult his or her own counsel, accountant or financial adviser as to the legal, tax and related matters concerning an investment in the Fund. Investors should inform themselves and should take appropriate advice on the legal requirements as to possible tax consequences, foreign exchange restrictions or exchange control requirements that they might encounter under the laws of the countries of their citizenship, residence or domicile and that might be relevant to the subscription, redemption or transfer of shares.

Prospectus  |  Subscription Agreement

Shares may be purchased only by submission of a Subscription Agreement to the Fund’s Registrar, Transfer Agent & Administrator or General Distributor or by contacting an authorized distributor.

This website is updated regularly; however, we do not assume any liability regarding the correctness or availability of any information contained herein, or that such information is current and up to date.

The value of the Shares and the return they generate can go down as well as up. They are affected by market volatility and by fluctuations in exchange rates. Upon redemption of Shares in the Fund, investors may not receive the full amount invested. Past performance is no indication of future results. Current tax levels and reliefs may change. Depending on individual circumstances, this may affect investment returns. The market price of Shares in the Fund may not reflect their underlying net asset value. For additional information in relation to the risk factors, please carefully read the section, Certain Risk Factors, in the current legal Prospectus.

Please note that no online subscriptions are available on this informative website. Subscriptions are valid only if made on the basis of the current Prospectus supplemented by the latest Annual Report and the latest Semi-Annual Report if published thereafter. Hard copies of the original English-language versions and German-language translation versions of the full and simplified Prospectus, the unaudited Semi-Annual Reports and the audited Annual Reports and the Articles of Incorporation can be obtained free of charge from the General Distributor at +44 22 70 1178 or For additional details in relation to the subscription procedure, please read the current legal Prospectus and Subscription Agreement.

This information does not replace the Prospectus or any other legal documents that can be obtained free of charge from the registered office of the Fund or from Carnegie Fund Services SA, 1204 Genève. It is not intended as an offer or solicitation with respect to the purchase or sale of shares of the UCITS. Stralem & Company Incorporated does not assume any liability in the case of incorrectly reported or incomplete information. Please be aware that investment funds involve investment risks, including the possible loss of the principal amount invested. For a detailed description of the risks in The Stralem Fund, please see the Prospectus.

The company’s Prospectus, the Articles of Incorporation, the Annual and Semi-Annual Report, as well as the list of the purchases and sales made during each accounting period can be obtained free of charge from the General Distributor and representative in Switzerland: Carnegie Fund Services S.A., 11, rue du Général-Dufour, 1204 Geneva. The Swiss paying agent is Banque Cantonale de Genève, 17, quai de l’Ile, 1204 Geneva.